Abstract
Topical delivery of macromolecules is a significant challenge. However, the increasing need in dermatology for the topical application of biodrugs, including proteins, peptides and nucleic acids calls for the development of novel approaches. In this perspective chapter we highlight several examples of advancement using physical and chemical methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baca-Estrada ME, Foldvari M, Babiuk SL, Babiuk LA (2000a) Vaccine delivery: lipid-based delivery systems. J Biotechnol 83:91–104
Baca-Estrada ME, Foldvari M, Ewen C, Badea I, Babiuk LA (2000b) Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system. Vaccine 18:1847–1854
Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–114
Benson HA (2006) Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv 3:727–737
Birchall JC, Marichal C, Campbell L, Alwan A, Hadgraft J, Gumbleton M (2000) Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome-plasmid DNA complexes. Int J Pharm 197:233–238
Bos JD, Meinardi MM (2000) The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9:165–169
Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G (1998) Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368:201–215
Charoo NA, Rahman Z, Repka MA, Murthy SN (2010) Electroporation: an avenue for transdermal drug delivery. Curr Drug Deliv 7:125–136
Delepine P, Guillaume C, Floch V, Loisel S, Yaouanc J, Clement J, Des Abbayes H, Ferec C (2000) Cationic phosphonolipids as nonviral vectors: in vitro and in vivo applications. J Pharm Sci 89:629–638
Elsabahy M, Foldvari M (2013) Needle-free gene delivery through the skin: an overview of recent strategies. Curr Pharm Des 19(41):7301–7315
Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA, Molina-Trinidad E, Casas-Alancaster N, Revilla-Vazquez AL (2011) Microneedles: a valuable physical enhancer to increase transdermal drug delivery. J Clin Pharmacol 51:964–977
Foldvari M (2000) Non-invasive administration of drugs through the skin: challenges in delivery system design. Pharm Sci Technol Today 3:417–425
Foldvari M (2010) Biphasic vesicles: a novel topical drug delivery system. J Biomed Nanotechnol 6:543–557
Foldvari M, Badea I, Wettig S, Baboolal D, Kumar P, Creagh AL, Haynes CA (2010) Topical delivery of interferon alpha by biphasic vesicles: evidence for a novel nanopathway across the stratum corneum. Mol Pharm 7:751–762
Glogau R, Blitzer A, Brandt F, Kane M, Monheit GD, Waugh JM (2012) Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines. J Drugs Dermatol 11:38–45
Gratieri T, Kalaria D, Kalia YN (2011) Non-invasive iontophoretic delivery of peptides and proteins across the skin. Expert Opin Drug Deliv 8:645–663
King MJ, Badea I, Solomon J, Kumar P, Gaspar KJ, Foldvari M (2002) Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. Diabetes Technol Ther 4:479–488
Lee JW, Gadiraju P, Park JH, Allen MG, Prausnitz MR (2011) Microsecond thermal ablation of skin for transdermal drug delivery. J Control Release 154(1):58–68. doi:10.1016/j.jconrel.2011.05.003
Lisziewicz J, Bakare N, Calarota SA, Banhegyi D, Szlavik J, Ujhelyi E, Toke ER, Molnar L, Lisziewicz Z, Autran B, Lori F (2012) Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against All HIV antigens in HIV-1 infected individuals. PLoS One 7, e35416
Mccrudden MT, Singh TR, Migalska K, Donnelly RF (2013) Strategies for enhanced peptide and protein delivery. Ther Deliv 4:593–614
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26:1261–1268
Puglia C, Bonina F (2012) Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 9:429–441
Schreief H, Bouwstrab J (1994) Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release 30:1–15
Schuetz YB, Naik A, Guy RH, Kalia YN (2005) Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin Drug Deliv 2:533–548
Shi Z, Curiel DT, Tang DC (1999) DNA-based non-invasive vaccination onto the skin. Vaccine 17:2136–2141
Shilpa S, Srinivasan BP, Chauhan M (2011) Niosomes as vesicular carriers for delivery of proteins and biologicals. Int J Drug Deliv 3:14–24
Watabe S, Xin KQ, Ihata A, Liu LJ, Honsho A, Aoki I, Hamajima K, Wahren B, Okuda K (2001) Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine 19:4434–4444
Xu Y, Hui SW, Frederik P, Szoka FC Jr (1999) Physicochemical characterization and purification of cationic lipoplexes. Biophys J 77:341–353
Yu WH, Kashani-Sabet M, Liggitt D, Moore D, Heath TD, Debs RJ (1999) Topical gene delivery to murine skin. J Invest Dermatol 112:370–375
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Foldvari, M., Kumar, P. (2017). Perspectives on Dermal Delivery of Macromolecular Drugs. In: Dragicevic, N., I. Maibach, H. (eds) Percutaneous Penetration Enhancers Drug Penetration Into/Through the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53270-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-662-53270-6_21
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53268-3
Online ISBN: 978-3-662-53270-6
eBook Packages: MedicineMedicine (R0)